15/04/2026
The Lung Health Foundation is proud to support the launch of the 2nd edition of the translational research grant program led by the Société de recherche sur le cancer / Cancer Research Society, focused on advancing lung cancer research.
With a total investment of $2 million, this initiative aims to accelerate progress in a field where the need remains urgent. In Canada, lung cancer is the leading cause of cancer-related death, yet it remains one of the most underfunded areas of research.
Through this program, four innovative research projects will each receive $500,000 over three years—helping bring new discoveries closer to real-world impact.
We’re proud to co-fund this work alongside the Fondation Bergeron-Jetté. Thank you to our partners for helping drive meaningful progress in lung cancer research!
The Cancer Research Society (CRS) is proud to announce the launch of the 2nd edition of its translational research grant program focused on lung cancer.
The CRS will invest a total of $2 million to accelerate progress in a field where needs remain significant. In Canada, lung cancer is the leading cause of cancer-related death, while also being one of the least funded areas in research.
This funding will support 4 innovative research projects, each receiving $500,000 over 3 years.
Thank you to our partners: the Fondation Bergeron-Jetté and the Lung Health Foundation, who will each co-fund one research project!
Discover more: https://loom.ly/bvUbuTk